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   Aim: 
Myocardial infarction is a life-threatening condition that occurs when blood flow to the 
heart is abruptly cut off, thereby causing tissue damage. The leaves of Nyctanthus arbor-tristis 
mainly used in ayurvedic, siddha, unani. Because of the presence of  more potent oleanolic acid 
in the leaves, the hydroalcoholic extract was therefore investigated for its cardioprotective 
activity in Nano-form. The present study was therefore aimed for Green synthesis and 
Cardioprotective activity of Nyctanthus arbor-tristis ZnO Nanoparticle against Isoproterenol 
Induced Myocardial Infarction in Rats.  
 
Green synthesis and Cardioprotective Activity of  
Nyctanthusarbor-tristis ZnO Nanoparticles  against 
Isoproterenol Induced Myocardial  Infarction in Rats. 
 Materials and methods  
Thirty Albino Wistar male Rats weighing 200-300 gm were randomly assigned to iver 
groups, each group containing 6 animals. Group I Control group- Received distilled water p.o 
for 14 days, Group II Negative control group- Received Isoproterenol (85 mg/kg) p.o, Group III 
Standard group - Received Propranolol (10 mg/kg/day), p.o, Group IV – Received HAE-NAT 
(500 mg/kg/day) p.o., Group V- Received ZnO NP-NAT (30 mg/kg) p.o. Myocardial Infarction 
was induced by intra peritoneal injection of Isoproterenol 85 mg/kg in two consecutive dose on 
14th and 15th day. The Nanoparticle was synthesized and evaluated against Isoproterenol 
induced MI by monitoring serum cardiac activity markers like AST,ALP, ALT,LDH,CK-MB. 
Changes were finally confirmed by Histopathological studies. 
 
Results:  
              In this study ,ZnO NP against  isoproterenol -induced animals exhibited significant 
increased in serum total cholesterol, TG, LDL level and decrease in HDL. And also serum 
cardiac activity markers CK -MB, LDH, ALT, AST and ALP were elevated, which were reserved 
to near normal levels in the treatment of ZnO NP in NAT. 
 
Conclusion:  
                 It might be concluded Hydroalcoholic  extract of Nyctanthus arbor tristis in 
cardioprotective activity which might be aid to reduce the myocardial infarction, Cardioprotective 
effect of ZnO NP was proved by reduction in cardiac marker enzymes, altered lipid profile and 
histopathological studies 
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MI Myocardial Infarction 
HAE Hydroalcoholic Extract 
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CHAPTER - 1 
INTRODUCTION 
Myocardial infarction (MI) or heart attack is one of the leading causes of death 
all over the world. It is caused due to an interruption in blood supply via the coronary 
circulation to any part of myocardium, resulting in myocardial necrosis1. 
Consequences of MI include hyperlipidemia, peroxidation of membrane lipids and 
loss of plasma membrane integrity. The pathogenesis of cardiac damage involves 
cell apoptosis, which is mainly influenced by oxidative-ROS production. Reactive 
oxygen species (ROS) play a critical role in the pathogenesis of cardiovascular injury 
associated with circulatory disturbance2.  
Despite major therapeutic advances, MI remains the major cause of death in 
india and increased mortality due to CVD is expected to be double by 20203. Hence 
Myocardial cell protection and prevention of cell ischemia/necrosis have been 
therapeutic targets for a long time. The allopathic medicines currently used to treat 
myocardial infarction have many side effects. Hence new therapies are needed to 
treat myocardial damage limiting its adverse effects and economical costs.  
The model of Isoproterenol-induced myocardial necrosis has the mechanism 
of generating ROS causing lipid peroxidation damage to the proteins due to 
production of carbonyl derivatives4. A disparity between the oxygen requirement of 
the myocardium and the ability of the coronary artery to meet it results in the 
ischemic necrosis of heart muscle. The pathophysiological changes following ISO 
administration are comparable to those taking place in human MI5. Hence this model 
is most widely used in order to study the beneficial effects of various herbal drugs on 
cardiac function6. 
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           Triterpenoids exists widely in nature and are the one of the major components 
of many traditional medicinal herbs. Oleanolic acid (OA) is a triterpenoid compound 
that exists widely in food and herbs7. It has variety of biological effects, such anti-
oxidants8, antifungal, anti-inflammatory, anti-hyperlipdemia, hepatoprotective, tumor 
prevention, immunomodulatory9, anti-HIV , anti-arrhythmic and cardiotonic10. Due to 
its anti-oxidant, anti-hyperlipedemic, antiarrhythmic, and cardiotonic effects, it will 
provide an accessible and cheap traditional medicine source for treatment of 
myocardial ischemia in developing countries. Hence current attention has been 
focused on phytoconstituents (OA) derived from plant species as potential 
therapeutic agents in the prevention and management of cardiovascular disease. 
              Nyctanthes, also known as Harsingar, is an important member of Ayurveda, 
the traditional Indian medicine science. It is blessed with a diverse spectrum of 
medicinal properties, such as anti-helminthic, antimicrobial, antiviral, antileishmania , 
anti-allergic, anti-diabetic and anti-cancerous. Juice of the leaves is used as 
digestives, antidote to reptile venoms, mild bitter tonic, laxative, diaphoretic and 
diuretic11.  The phytochemical characterization of Nyctanthus arbour-tristis reveals 
the presence of robust bioactive Triterpenoid compound, Oleanolic acid12. Hence this 
boosts up in investigating the effect of leaves on Isoproterenol-induced cardiac 
injury. Previously reported articles on Oleonolic acid and myocardial damage 
prompted our further research to deal with Cardioprotective activity of the plant.  
              Nanoparticles hold extraordinary and attractive properties due to their small 
sizes, large surface area, free hanging bonds and superior reactivity. Nowadays, 
nanotechnology has a vast range of application in diagnosis, drug delivery, food 
industry, paints, electronics, sports, environmental cleanup, cosmetics, and 
sunscreens. Green synthesis approaches of herbal extracts are gaining interest 
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towards treatment of various diseases. Recently, plants and their extracts based 
nanoparticles synthesis were considered to be the best techniques because of easy 
availability, mass production and eco-friendly process. Zinc (Zn) an essential 
micronutrient that exhibits antioxidant properties and protects cardiac cells against 
different oxidative stressors13. According to some previous studies, Zinc oxide 
nanoparticles (ZnO NPs) are found to be non-toxic, biosafe, biocompatible making 
them an ideal candidate for biological applications.   
                The plant Nyctanthes extracts have been reported to yield gold, silver and 
titanium dioxide Nanoparticles. Two majorly researched substrates for biosynthesis 
of ZnONPs are zinc acetate and zinc nitrate . This is, to the best of our knowledge, 
the first study reporting synthesis of zinc oxide Nanoparticles using leaf extract of 
Nyctanthes arbor-tristis and zinc acetate. The present study was therefore aimed to 
determine the Cardioprotective effect of NA-ZnO NP against Isoproterenol induced 
Myocardial Infarction in Rats. 
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CHAPTER – 2 
LITERATURE REVIEW 
2.1. MYOCARDIAL INFARCTION 
 A myocardial infarction is a life-threatening condition that occurs when blood 
flow to the heart is abruptly cut off, causing tissue damage. This is usually the result 
of a blockage in one or more of the coronary arteries.  
           A blockage can develop due to a buildup of plaque, a substance mostly made 
of fat, cholesterol, and cellular waste products14 .Coronary atherosclerosis is a 
chronic disease with stable and unstable periods. During unstable periods with 
activated inflammation in the vascular wall, patients may develop a myocardial 
infarction. Myocardial infarction may be a minor event in a lifelong chronic disease, it 
may even go undetected, but it may also be a major catastrophic event leading to 
sudden death or severe hemodynamic deterioration. A myocardial infarction may be 
the first manifestation of coronary artery disease, or it may occur, repeatedly, in 
patients with established diseases15. 
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             Figure 1: Pathophysiology of Myocardial Infarction 
2.1.1. SYMPTOMS 
The symptoms can be quite varied. The most common symptoms of a heart 
attack include, 
 Pressure or tightness in the chest 
 Pain in the chest, back, jaw, shoulder and other areas of the upper body that 
lasts more than a few minutes or that goes away and comes back. 
 Shortness of breath 
 Sweating 
 Nausea 
 Vomiting 
 Anxiety 
 Cough 
 Dizziness 
 Fast heart rate 
Literature review 
 
M. Pharm Project Page 6 
 
It’s important to note that not all people who have heart attacks experience the same 
symptoms or the same severity of symptoms. Chest pain is the most commonly 
reported symptoms among both women and men. 
2.1.2. PATHOPHYSIOLOGY        
 
                 Most myocardial infarctions are caused by a disruption in the vascular 
endothelium associated with an unstable atherosclerotic plaque that stimulates the 
formation of an intracoronary thrombus, which results in coronary artery blood flow 
occlusion. If such an occlusion persists for more than 20 minutes, irreversible 
myocardial cell damage and cell death will occur. The two primary characteristics of 
the clinically symptomatic atherosclerotic plaque are a fibro muscular cap and an 
underlying lipid-rich core. Plaque erosion can occur, because of the actions of matrix 
metallo proteases and the release of other collagenases and proteases in the 
plaque, which result in thinning of the overlying fibro muscular cap. The action of 
proteases, in addition to hemodynamic forces applied to the arterial segment, can 
lead to a disruption of the endothelium and fissuring or rupture of the fibro muscular 
Figure 2:  Schematic representation of MI 
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cap. The loss of structural stability of a plaque often occurs at the juncture of the 
fibro muscular cap and the vessel wall, a site otherwise known as the shoulder 
region. Disruption of the endothelial surface can cause the formation of thrombus via 
platelet-mediated activation of the coagulation cascade. If a thrombus is large 
enough to occlude coronary blood flow, an MI can result. 
The death of myocardial cells first occurs in the area of myocardium, most 
distal to the arterial blood supply: the endocardium. As the duration of the occlusion 
increases, the area of myocardial cell death enlarges, extending from the 
endocardium to the myocardium and ultimately to the epicardium. The area of 
myocardial cell death then spreads laterally to areas of watershed or collateral 
perfusion. Generally, after a 6 to 8 hour period of coronary occlusion, most of the 
distal myocardium has died. The extent of myocardial cell death defines the 
magnitude of the MI. If blood flow can be restored to at-risk myocardium, more heart 
muscle can be saved from irreversible damage or death. 
           The severity of an MI depends on three factors: 
                      1) The level of the occlusion in the coronary artery,  
                      2) The length of time of the occlusion,  
                      3) The presence or absence of collateral circulation. 
 Generally, the more proximal the coronary occlusion, the more extensive the 
amount of myocardium that will be at risk of necrosis. The larger the myocardial 
infarction, the greater the chance of death because of a mechanical complication or 
pump failure. The longer the period of vessel occlusion, the greater the chances of 
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irreversible myocardial damage distal to the occlusion. Myocardial necrosis begins at 
approximately 30 minutes after coronary occlusion. Classic acute MI with extensive 
damage occurs when the perfusion of myocardium is reduced severely below its 
needs for an extended interval (usually atleast 2 to 4 hours) causing profound 
ischemia and resulting in permanent loss of function of large regions in which cell 
death has occurred16. 
2.1.3. CLASSIFICATION 
Myocardial infarctions are generally classified into ST elevation MI (STEMI) 
and non-ST elevation MI (NSTEMI). STEMI is the combination of symptoms related 
to poor oxygenation of the heart with elevation of the ST segments on the 
electrocardiogram followed by an increase in proteins in the blood related to heart 
muscle's death. They make up about 25 to 40 percent of cases.  
The phrase "heart attack" is often used non-specifically to refer to a 
myocardial infarction and to sudden cardiac death. An MI is different from cardiac 
arrest, but can cause cardiac arrest, where the heart is not contracting at all or so 
poorly that all vital organs cease to function. It is also distinct from heart failure, in 
which the pumping action of the heart is impaired. However, an MI may lead to heart 
failure. 
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                                  Fig.3: Acute Coronary Syndrome 
                                          NQMI- Non Q-Wave myocardial infarction. 
                                          QWMI- Q-Wave Myocardial Infarction. 
MI is classified into five main types:  
Type 1 – Spontaneous MI related to ischemia due to a primary coronary event 
such as plaque erosion and/or rupture, fissuring, or dissection. 
Type 2 – MI secondary to ischemia due to either increased oxygen demand or 
decreased supply, e.g. coronary artery spasm, coronary embolism, 
anemia, arrhythmias, hypertension, or hypotension 
Type 3 – Sudden unexpected cardiac death, including cardiac arrest, often  
                     with Symptoms suggestive of myocardial ischemia, accompanied  
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                      by new  ST Elevation, or new left bundle branch block (LBBB),   
Type 4 – Associated with coronary angioplasty or stents. 
 Type 4a – MI associated with percutaneous coronary intervention (PCI). 
 Type 4b – MI associated with stent thrombosis as documented by 
angiography or at autopsy. 
Type 5 – MI associated with CABG. 
        The terms Q wave and non-Q wave MI were previously used to indicate 
STEMI and non-STEMI respectively 17. 
2.1.4. ETIOLOGY 
Acute coronary syndromes (ACS) are associated with structurally as well as 
functionally complex plaques and coronary artery stenoses, coronary endothelial 
lesions, and plaque inflammation18. Structural morphology, cellular composition, and 
biological activity of coronary plaques appear to be closely linked. Plaque instability 
correlated more with biological activity and cellular composition than with 
angiographical findings19. Exogenous factors (e.g. mechanical stress, vasomotor 
tone, infection, blood viscosity, coagulability) further modify such interaction, making 
the final outcome even less predictable. Systemic or multi-focal arterial inflammation 
may be independent risk factors for acute coronary events. 
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Thrombosis – The most common cause 
The common cause of an MI is a blood clot (thrombosis) that forms inside a 
coronary artery or one of its branches and blocks the blood flow to a part of the 
heart.  
Blood clots do not usually form in normal arteries. However, a clot may form if 
there is some atheroma within the lining of the artery. Atheroma is the technical term 
for fatty patches or ’plaques’. Plaques of atheroma may gradually form over a 
number of years in one or more places in the coronary arteries. Each plaque has an 
outer firm shell with a soft inner fatty core. What happens is that a ’crack’ (plaque 
rupture) develops in the outer shell of the atheroma plaque. This exposes the softer 
inner core of the plaque to blood and can trigger the clotting mechanism in the blood 
to form a blood clot. Therefore, a buildup of atheroma is the root problem that leads 
to most cases of MI 20.     
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    Fig .4: Atheroma formation in Heart                    
2.1.5. Complication  of myocardial infarction
I    
                             Fig.5 : Complication  of myocardial infarction 
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Complications of MI are failure of reperfusion (ischemic), cardiac rupture, 
thrombosis and emboli, heart failure, psychological complications including 
depression and pericarditis, contractile dysfunction, arrhythmias, papillary muscle 
dysfunction21.The pumping ability of heart is reduced, if a large area of heart muscle 
is damaged. This causes the occurrence of other complications after myocardial 
infarction because less blood is pumped around body. These complications include 
heart failure, swollen ankles, tiredness and breathlessness. If electrical activity of 
heart is affected, abnormal heart rhythms, fast or chaotic heart beats may occur. An 
immediate electrical shock treatment given by defibrillator is needed. If further 
buildup of atheroma continues or coronary arteries are badly affected, there is more 
likely to have the occurrence of myocardial infarction in future22. 
MAJOR COMPLICATION IS HEART FAILURE 
Heart failure (HF) is a frequent complication of myocardial infarction (MI). Several 
factors as follows, 
 Myocardial ischemia 
 Infarct size 
 Ventricular remodeling 
 Stunned myocardium 
 Mechanical complications, and hibernating  
 Myocardium influence the appearance of left ventricular systolic dysfunction 
with or without clinical HF after MI 23. 
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              Fig .6: Structure of normal and abnormal heart 
2.1.6. RISK FACTORS FOR MYOCARDIAL INFARCTION 
Predisposing risk factors for myocardial infarction are generally divided into 
two categories.  
 Non -modifiable risk factors   
 Modifiable risk factors  
     According to Interheart study, risk factors for MI are divided into 2 categories i.e. 
 Emerging risk factors (homocysteine, glucose abnormalities, nutritional 
factors, abdominal obesity and psychosocial factors) and  
 Conventional risk factors (hypertension, diabetes, smoking and 
elevated cholesterol) between people of varying geographic and ethnic 
origin. However, these known risk factors would explain only about 
50% of cases of heart disease.  Moderate or strenuous exercise, 
consumption of alcohol (≥ 3 times per week) and daily consumption of 
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fruits and vegetables prove to be protective24. Nine different factors 
predispose the risks of MI worldwide. 
2.1.6.1.MODIFIABLE PREDISPOSING RISK FACTORS 
 Smoking 
Smoking is considered as strong risk factor for myocardial infarction, 
premature atherosclerosis and sudden cardiac death. Smoking results in early 
STEMI especially in otherwise healthier patients. Smoking causes an average of 7 
years earlier and more likely twice the chances of infarction than non smokers30. 
 Physical activity 
  Inactive people with multiple cardiac risk factors are more likely to develop 
MI. To get benefit, these individuals should start from modest exercise training. 
There should be aggressive risk factor modification before performance of vigorous 
activity. 
 LDL and triglyceride levels 
Elevated triglyceride levels and dense, small LDL particles act as 
predisposing risk factors for MI. Non fasting triglyceride levels appear to be a strong 
and independent predictor of future risk of MI, particularly when the total cholesterol 
level is also elevated. The reason behind it is that decreased HDL-C levels and 
increased triglyceride levels cause metabolic perturbations thus causing adverse 
consequences. To identify high risk individuals, elevated triglyceride levels may 
become markers. 
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 Obesity/ Body mass index (BMI) 
 Increased BMI is directly related to incidence of MI. Infarction is greatly 
enhanced by extreme obesity because it is a recognized risk factor for MI. To reduce 
the population burden of MI in US, strategies are devised to promote optimal body 
weight25. 
 Diabetes mellitus (DM) 
 Significant differences in parameters measured were noted when all diabetic 
and non-diabetic patients were compared to the control group. It was found that in 
men with myocardial infarction there are significant differences between diabetic and 
nondiabetic patients with respect to certain risk factors such as age, hypertension 
and hypertriglyceridemia in diabetic patients, while smoking and family history are 
predominant factors in non diabetic patients. However, newly diagnosed diabetic 
men have similar risk profiles to their known diabetic counterparts. 
 Hypertension 
Hypertension is strong and independent risk factor for MI. It is major risk 
factor of causing atherosclerosis in coronary blood vessels, result in heart attack or 
MI. Hypertension and MI are closely linked. 
 Psychosocial Stress 
       Chronic life stress, social isolation and anxiety increase the risk of heart attack 
and stroke.  
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2.1.6.2. NON -MODIFIABLE PREDISPOSING RISK FACTORS   
   Increasing age is more likely to die of heart disease. About 80% of heart 
disease deaths occur in people aged 65 or older. Gender Men tend to have heart 
attacks earlier in life than women. Women's rate of heart attack increases after 
menopause, but does not equal men's rate. Even so, heart disease is the leading 
cause of death for both men and women.  
 Heredity/Family history 
 Increased risk, if a first degree blood relative had coronary heart disease or 
stroke before the age of 55 years for male relative and 65 years for female relatives.  
 Genetic factor 
Coronary artery disease and myocardial infarction are the most frequent 
causes of death. Even nowadays, every second myocardial infarction is lethal and 
hits the patients unexpectedly without previous signs or symptoms.   These are the 
risk factors which causes MI. 
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2.2. NANOPARTICLES 
           Nano particles are particles between 1 and 100 nanometer (nm) in size with a 
surrounding interfacial layer. The interfacial layer is an integral part of nanoscale 
matter, fundamentally affecting all of its properties. The interfacial layer typically 
consists of ions, inorganic and organic molecules. Organic molecules coating 
inorganic nanoparticles are known as stabilizers, capping and surface ligands, or 
passivating agents26. In nanotechnology a particle is defined as a small object that 
behaves as a whole unit with respect to its transport and properties. Particles are 
further classified according to diameter27. 
2.2.1. Classification of Nanoparticles 
Nanoparticles are broadly classified in to three classifIcations28. 
• One dimension nanoparticles 
      One dimensional system (thin film or manufactured surfaces) has been used  
fordecades. Thin films (sizes 1–100 nm) or monolayer is now common place in the 
field of solar cells offering, different technological applications, such as chemical and 
biological sensors, information storage systems, magneto-optic and optical device, 
fiber-optic systems. 
 
• Two dimension nanoparticle 
       Carbon nanotubes. 
 
• Three dimension nanoparticles 
      Dendrimers, Quantum Dots, Fullerenes (Carbon 60), (QDs) 
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2.2.2. Characterization of Nanoparticles 
         Characterization of nanoparticles is based on the size, morphology and surface 
Charge, using such advanced microscopic techniques as atomic force microscopy 
(AFM), scanning electron microscopy (SEM) and transmission electron microscopy 
(TEM). Properties such as the size distribution, average particle diameter, and 
charge affect the physical stability and the in vivo distribution of the nanoparticles. 
Properties like surface morphology; size and overall shape are determined by 
electron microscopy techniques. Features like physical stability and redispersibility of 
the polymer dispersion as well as their in vivo performance are affected by the 
surface charge of the nanoparticles. It is very important to evaluate the surface 
charge during characterization of nanoparticles. 
2.2.2.1. Particle Size 
         Characterizations of nanoparticles are primarily evaluated by the particle size 
distribution and morphology. With the aid of electron microscopy it’s now possible to 
ascertain the morphology as well as the size of nanoparticles. Application of 
nanoparticles in drug release and drug targeting can be conveniently determined by 
various tools. It has already been reported that particle size of nanoparticles has 
profound effect on the drug release. 
         Smaller the size of nanoparticles larger surface area, which results in to fast 
drug release. Loaded drug when exposed to the particle surface area causes 
significant drug release. In contrast, inside the nanoparticles drugs slow diffusion of 
larger particles occurs.  
         Consequently smaller particles tend to aggregate during storage and 
transportation of nanoparticle dispersion. Therefore there is a mutual compromise 
between maximum stability and small size of nanoparticles29. In addition degradation 
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of the polymer can also be affected by the particle size e.g. the extent of poly (lactic-
co-glycolic acid) degradation was found to increase with increasing particle size in 
vitro30. 
2.2.2.2.B. Scanning Electron Microscopy (SEM) 
              This electron microscopy based technique determines the size, shape and 
surface morphology with direct visualization of the nanoparticles. Therefore scanning 
electron microscopy offer several advantages in morphological and sizing analysis. 
However they provide limited information about the size distribution and true 
population average.  
              During the process of SEM characterization, solution of nanoparticles 
should be initially converted into a dry powder. This dry powder is then further 
mounted on a sample holder followed by coating with a conductive metal (e.g. gold) 
using a sputter coater. Whole sample is then analyzed by scanning with a focused 
fine beam of electrons31. 
              Secondary electrons emitted from the sample surface determine the surface 
characteristics of the sample. This electron beam can often damage the polymer of 
the nanoparticles which must be able to withstand vacuum. Average mean size 
evaluated by SEM is comparable with results obtained by dynamic light scattering. In 
addition these techniques are time consuming, costly and frequently need 
complementary information about sizing distribution. 
 
 
2.2.2.4. Transmission Electron Microscope 
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             Transmission electron microscopy techniques can provide imaging, 
diffraction and spectroscopic information, either simultaneously or in a serial manner, 
of the specimen with an atomic or a sub-nanometre spatial resolution.      
            TEM operates on different principle than SEM, yet it often brings same type 
of data. The sample preparation for TEM is complex and time consuming because of 
its requirement to be ultra thin for the electron transmittance32.High-resolution TEM 
imaging, when combined with nano diffraction, atomic resolution electron energy-
loss spectroscopy and nanometre resolution X-ray energy dispersive spectroscopy 
techniques, is critical to the fundamental studies of importance to nanoscience and 
nanotechnology.  
           During the TEM characterization nanoparticles dispersion is deposited onto 
support grids or films33. After dispersion they are fixed using either a negative 
staining material (phosphotungstic acid or derivatives, uranyl acetate, etc., or by 
plastic embedding). 
 
2.2.2.5. Surface Charge  
                 Surface charge and intensity determines the interaction of nanoparticles 
with the biological environment as well as their electrostatic interaction with bioactive 
compounds. Stability of colloidal material is usually analyzed through zeta potential 
of nanoparticles.  
                 Zeta potential is an indirect measure of the surface charge. It can be 
obtained by evaluating the potential difference between the outer Helmholtz plane 
and the surface of shear. Thus zeta potential of colloidal based dispersion assists 
indirectly evaluating its storage stability. Zeta potential values (high zeta potential 
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values, either positive or negative) are achieved in order to ensure stability and avoid 
aggregation of the particles. 
                 Zeta potential values can be utilized in evaluating surface hydrophobicity 
and the nature of material encapsulated within the nanocapsules 
or coated onto the surface34. 
 
2.2.2.6. Surface Hydrophobicity   
          Techniques such as hydrophobic interaction chromatography, biphasic 
partitioning, adsorption of probes, contact angle measurements etc. can be utilized 
for the determination of surface hydrophobicity. Recent advancement in research 
offers several sophisticated analytical tools for surface property analysis of 
nanoparticles. Modern technique such as X-ray photon correlation spectroscopy not 
only determine surface hydrophobicity but also permits the identification of specific 
chemical groups on the surface of nanoparticles35. 
 
2.2.2.7. Drug Release  
                  It’s very essential to determine extent of the drug release and in order to 
obtain such information most release methods require that the drug and its delivery 
vehicle be separated. Drug loading capacity of the nanoparticles is defined as the 
amount of drug bound per mass of polymer or in another term it is the moles of drug 
per mg polymer or mg drug per mg polymer or it could also be given as percentage 
relative to the polymer36. 
                       Various techniques such as UV spectroscopy or high performance liquid 
chromatography (HPLC) after ultracentrifugation, ultra filtration, gel filtration, or 
centrifugal ultra filtration are used to determine this parameter. Methods that are 
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employed for drug release analysis are also similar to drug loading assay which is 
more often assessed for a period of time to evaluate the drug release mechanism. 
 
2.2.3. Preparation of Nanoparticles 
                 The preparation of nanoparticles depends on the physicochemical 
character of the polymer and the drug to be loaded. Nanoparticles can be prepared 
from a variety of materials such as proteins, polysaccharides and synthetic polymers. 
The selection of matrix materials is dependent on many factors including37. 
                    • Antigencity of the final product. 
                    • Biocompatibility and toxicity 
                    • Degree of biodegradability 
                    • Drug release profile desired 
                    • Inherent properties of the drug (aqueous solubility and stability) 
                    • Size of nanoparticles required 
                    • Surface characteristics (charge and permeability) 
Nanoparticles have been usually prepared by three methods: 
                     • Dispersion of preformed polymers 
                     • Ionic gelatin or coacervation of hydrophilic polymers 
                     • Polymerization of monomers 
 
2.2.4. Properties of nanoparticles 
 Nanoparticles are of great interest because of their unique 
properties.  
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 Bulk material has constant physical properties regardless of its 
size, the properties of materials change as their size reduces to 
nanoscale. 
 Nanoparticles have large surface area to volume ratio as 
compared to its bulk material. 
 Nanoparticles are very small in size due to which quantum effects 
arise and hence nanoparticles have optical properties.  
 Clay nanoparticles are integrated into polymer matrices to 
increases the reinforcement leading to stronger plastics. 
 Nanoparticles are semiconductor devices, radiation therapy, solar 
cells, synthetic fibers etc 
 Nanoparticles can be used for anti-reflection product coatings. 
 
2.2.5. Green synthesis of nanoparticles 
               “Green synthesis” of nanoparticles makes use of environmental friendly, 
non-toxic and safe reagents. Nano particles synthesized using biological techniques 
or green technology have diverse natures, with greater stability and appropriate 
dimensions since they are synthesized using a one-step procedure38.  
              Nanoparticles can be synthesized using a variety of methods including 
chemical, physical, biological, and hybrid techniques. 
             Physical methods including plasma arcing, ball milling, laser desorption, 
lithographic techniques, sputter deposition, layer by layer growth, molecular beam 
epitasis and diffusion flame synthesis of nanoparticles.  Similarly, chemical methods 
are used to synthesize NPs by electro deposition, sol–gel process, chemical solution 
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deposition, chemical vapour deposition soft chemical method, Catalytic route, 
hydrolysis co-precipitation method and wet chemical method 39.  
         Chemical and Physical methods have been using high radiation and highly 
concentrated reductants and stabilizing agents that  are harmful for the 
environmental and to human health. Hence, biological synthesis of nanoparticles is a 
single step bio-reduction method and less energy is used to synthesize eco-friendly. 
 
Advantages of green synthesis 
 Green synthesis encapsulate the nanoparticles. So prevent instant 
reaction. 
 Easily scaled up for large synthesis of nanoparticles 
 No need of high temperature, pressure, energy, and toxic chemicals 
 Maintenance cost is much less 
 Acts as both reducing and stabilising agents. 
 Reduce toxicity 
 Highly stable and rapid synthesis 
 Environmental friendly 
 
2.2.6. Metal ions used in nanoparticles 
                        
 Gold 
 Silver 
 Zinc 
 Iron 
 Titanium 
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2.2.7. Gold nanoparticles 
               A gold-based nanoparticle has reported to be effective of antibacterial 
agents. Transcriptomic and proteomic data show the down-regulation of atpD and 
atpA, which are subunits of F-type ATP synthase. The down-regulation could lead to 
a decrease of the activity of F-type ATP synthase. To test this hypothesis, we 
extracted the membrane protein of gold NP-treated or untreated E. coli and 
determined the activity of F-type ATP synthase. 
                 Gold NPs can severely decrease the activity of F-type ATP synthase F-
type ATP synthase plays a major role in the process of ATP synthesis; its decrease 
can directly lead to the decrease of the ATP level. As expected, we found that the 
ATP level significantly decreased in NP-treated E. coli. The biological function of 
ATP synthase is dependent on the membrane potential. We further investigated the 
effects of gold NPs on cytoplasmic membrane potential of E. coli via a fluorescent 
probe, DiSC3 (5) dye, which can be quenched by the electrically polarized 
membrane40. 
                When the membrane potential collapses, the probe releases into the 
cytoplasm and leads to an increase in fluorescence. The fluorescence of NP-treated 
E. coli was significantly increased compared with that of untreated E. Coli.   
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 Fig.No :7 Mechanism of action of gold nanoparticles in bactericidal agents   
 
2.2.8. Silver nanoparticles 
               Silver nanoparticles are nanoparticles of silver which are in the range of 1 
and 100 nm in size. Silver nanoparticles have unique properties which help in 
molecular diagnostics, in therapies, as well as in devices that are used in several 
medical procedures. 
              The major methods used for silver nanoparticle synthesis are the physical 
and chemical methods41.  The major biological systems involved in this are bacteria, 
fungi, and plant extracts. The major applications of silver nanoparticles in the 
medical field include diagnostic applications and therapeutic applications. In most of 
the therapeutic applications, it is majorly used antimicrobial property. 
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         Fig.No: 8  Mechanism of action of silver nanoparticles in bacteria 
 
 
 
2.2.9. Zinc nanopartiocles 
             Zinc is an essential metallic micronutrient with a potential association with 
CVD. The importance of zinc is apparent from the enormous number of proteins that 
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contain zinc ions in their structure41. Intracellular zinc plays a critical role in the redox 
signaling pathway, where by deficiency of zinc under oxidative stress leads to the 
degradation of critical proteins, as shown for protein kinase C (PKC) . 
             Zinc plays a role in cardiovascular physiology and pathology. Several 
investigators have shown decreased blood zinc levels in Patients with 
ischemia/myocardial infarction, congestive heart failure, conduction abnormalities, 
and heart transplant, resulting in poor outcomes.       
 
 
 
 
 
                        Fig.No:9  Intracellular role of zinc homeostasis 
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               Fig.No: 10  Role of zinc ions in cardiovascular system 
 
2.2.10. Iron nanopartiocles 
 
            Iron nanoparticles have been employed for targeted delivery systems for the 
delivery of DNA enzyme for the treatment of hepatitis C. The nanoparticles induced 
the knock down of hepatitis C virus gene, NS3. HCV NS3 gene encodes helicase 
and proteases which are useful for viral replication42.  
             The nano formulation did not suffer from severe immune responses. In vivo 
evaluation on mice showed that after administration on the animal models, the 
nanoparticles accumulated in the hepatocytes and macrophages in the liver 
suggesting their potential application for the treatment of hepatitis C. 
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2.2.11. Titanium nanoparticles 
  
          Because of its photosensitivity, nano-TiO2 can become a substance that 
generates reactive oxygen species (ROS) in the body43. Under normal conditions, 
ROS play an important role in anti-bacterial and anti-inflammatory processes and 
can suppress tumours. However, disease or some exogenous poisons may cause 
disorders in the body’s anti-oxidation system, resulting in radical metabolic 
imbalances and abnormal increases in ROS. Excessive ROS produce toxicity, 
resulting in the formation of biofilms and macromolecular substances that induce 
lipid peroxidation damage. 
 
     Fig.No:11  Process by which TiO2 nanoparticles produce ROS in     
                                                  mitochondria. 
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  2.3. NYCTANTHUS ARBOR-TRISTIS 
   Nyctanthus arbor-tristis Linn is a small scared ornamental tree known across the 
country for  its fragrant while flower44. Nyctanthus arbor-tristis Linn is commonly 
known as Night jasmine or parijata. 
                               Plant name      :        Nyctanthus arbor-tristis 
                                Family            :        Oleaceae 
2.3.1. Vernacular names 
                              Tamil                    :        Pavala- malligai, Manjhapu 
                              English                 :        Night jasmine, Coral jasmine 
                              Hindi                    :        Harsinghar, Seoli, Sihau 
                              Sanskrit                :        Parijatha, parijatah, sephalika 
                              Malayalam           :        Mnnapu, Pavizhamalli, Parijatak 
                              Telugu                  :        Kapilanagadustu, Pagadamalle 
                              Kannada              :         Goli, Harsing, Parijata 
                              Marathi                :        Kharbadi, Kharassi, Khurasli. 
                              Gujarathi              :        Jayaparvati 
                              Punjabi                 :        Harsinghar 
2.3.2. Taxonomical name 
                              Kingdom               :       Planate 
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                              Order                     :       Lamiale 
                              Division                 :       Magnoliophyt 
                              Class                      :       Magnoliopsida 
                              Family                   :       Oleaceae 
                              Genus                    :        Nyctanthes 
                              Species                  :        Arbortristis45. 
2.3.3. Plant diagram 
 
                                                                                                                                                                                                                                                                   
                                                                                                       
    
 
 
 
       Fig.No:12 Aerial parts of Nyctanthus arbor-tristis & Powder of Nyctanthus arbor-
tristis 
                              
    2.3.4. Morphology 
                              Colour: Light to dark green 
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                              Odour: Indistinct 
                              Taste: Bitter and astringent 
                              Leaf: Simple, 5-14 cm long, 2.5-7.5 cm wide, ovate, acute   
                                 Margin: Entire or distinctly toothed Base and  Round  
                              Venation: Reticulate, lateral vein 3-6 pairs 
2.3.5. Phytoconstituents of Nyctanthus arbor- tristis 
2.3.5.1. Leaves 
                Three new benzoic esters of Loganin and 6-β-hydroxy loganin, namely 
Arborside-A, Arborside-B, and Arborside-C were found to be present in the leaves. From 
leaves 10-Benzoylnyctanthoside named as Arborside-D were isolated. Other iridoid 
glycosides that were reported are 6, 7-Di-O-benzoyl nyctanthoside, 6-O-transcinnamoyl-
6-β-hydroxy loganin and 7-O-trans cinnamoyl-6-β-hydroxy loganin from the leaves. A 
phenyl propanoid glucoside Des rhamnosyl verbascoside was reported from the leaves. 
Leaves also contain the alkaloid Nyctanthine along with Mannitol, β-Amyrin β-Sitosterol, 
Hentriacontane, Benzoic acid, Astragalin, Nicotiflorin, Oleanolic acid, Nyctanthic acid, 
Friedelin and Lupeol46. 
                
2.3.5.2. Flowers 
           Essential oil, nyctanthin, d- mannitol, tannin and glucose, carotenoid, Glycosides, 
β- mono gentiobioside, β-D monoglucoside ester of α-crocetin, β-digentiobioside ester of 
α-crocetin. 
 
2.3.5.3. Stem  
         Glycoside-naringenin-4’-o- β-glucapyranosyl- α-xylopyranoside was screened from 
the stem chromatographed the chloroform extract of the stem over silica gel column and 
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reported the presence of β-Amyrin, Arbortristoside-A, Oleanolic acid, Nyctoside-A, 
Nyctantic acid and 6-β-hydroxyloganin.  
      2.3.5.4. Seeds 
            Seeds give a water soluble polysaccharide containing D-Glucose and D-
Mannose, indicating that the polysaccharide is a glucomannan. Iridoid glycosides 
Arbortristoside-A, Arbortristoside B, Arbortristoside-C and 6-β-hydroxyloganin have been 
isolated. Further examination of the seeds led to the isolation and identification of two 
minor iridoid glucosides, Arbortristoside-D and Arbortristoside-E together with the 
previously reported Arbortristoside-B. Other iridoid glucoside reported are Nyctanthoside, 
A phenyl propanoid glucoside, Nyctoside-A was isolated from the methanolic extract of 
the seeds.  
2.3.6 Traditional uses 
2.3.6.1 Leaves 
         The leaves of Nyctanthus arbor-tristis Linn. are mainly used in ayurvedic. The 
Parijatha is regarded in Hindu mythology as one of the five grating trees of Devaloka47. 
        Different parts of Nyctanthus arbor-tristis Linn are used in Ayurveda, Sidda, and 
Unani system of medicines. Treatment of various diseases such as Sciatica, chronic 
fever, rheumatism,and internal worm infections, and as laxative, diaphoretic and 
diuretic48.Leaves are mainly used in the enlargement of spleen. Paste of leaves is mixed 
with honey for the treatment of blood pressure, diabetes and fever49.The decoction of the 
leaves is mainly used by Ayurvedic physicians for the treatment of arthritis, malaria, 
intestinal worms, obstinate sciatica, cholagogue and laxative. The leaf juice is used to 
treat loss of appetite, piles, liver disorders, biliary disorders, intestinal worms, chronic 
fever, obstinate sciatica, rheumatism and fever with rigors. The extracted juice of leaves 
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acts as a cholagogue, laxative and mild bitter tonic. It is given with little sugar to children 
as a remedy for intestinal ailments 50. 
2.3.6.2. Flowers 
          The flowers are used as stomachic, carminative, astringent to bowel, antibilious, 
expectorant, hair tonic and in the treatment of piles and various skin diseases and in the 
treatment of ophthalmic purposes. The bright orange corolla tubes of the flowers contain 
a colouring substance nyctanthin, which is identical with Crocetin from Saffron. The 
corolla tubes were formerly used for dyeing silk, sometimes together with Safflower or 
turmeric51. 
 2.3.6.3. Stem  
The powdered stem bark is given in rheumatic joint pain. Used as expectorant. Bark is 
mainly used for the snakebite and bronchitis52. 
2. 2.3.6.4. Seed  
           The seeds are used as anthelmintics and in alopecia. It is antibilious and an 
expectorant, and is also useful in bilious fever. The powdered seeds are used to cure scurfy 
affections of scalp, piles and skin diseases 53. 
 
2.3.7. Pharmacological action of N. arbor- tristis 
 Antibacterial activity 
 Anticancer activity 
 Anthelmintic  activity 
 Analgesic and Anti inflammatory  activity 
 Hypoglycemic  activity 
 Larvicidal activity 
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 Invitro anti-oxidant activity 
 Immuno pharmacological activity 
    2.3.7.1 Antibacterial activity 
                  The antibacterial activities of Nyctanthus arbor- tristis L., seed and fruit 
extract were used for their antibacterial screening. Melanin content and stability of 
the fruit and seed were studied against various factors like temperature, oxidants 
and metal ions. Phytochemical analysis shows the presence of phytosterols. 
Steroids were present in seeds. UV spectral studies show high content of melanin in 
seeds54. Chloroform and ethyl acetate extracts of fresh leaf, seeds and fruits were 
showed significant antibacterial activity against Gram negative bacteria (E.coli and K. 
Pneumonise) and Gram positive bacteria (S.aureus), where as dried extract of 
chloroform and ethyl acetate shown significant antibacterial activity against 
pseudomonas aeruginosa. 
2.3.7.2 Anticancer activity 
         Methanol extract of fruit, leaf and stem of N.arbor-tristis were tested in vitro 
cancer activities. Moderate activity was observed at 30mg/ml conc. with 71% 
inhibition of dried NAT leaf methanol extract and least inhibitory activity was 
observed at 10mg/ml conc. With 86% inhibition of Breast cancer cell lines free of 
pathogens. The phytochemicals isolated from NAT dried fruits methanol are 
glycosides, tannins, phenols and steroids and are predicted to responsible for this 
cancer activities55. 
2.3.7.3 Anthelmintic activity 
               In vitro anthelmintic activity of nyctanthus arbor-tristis Linn bark, parasite 
diseases causes severe morbidity by affect the population. More than half of the 
population of the world suffers various types of infections and suffer from worm 
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infections. Alcohol and aqueous extracts from the bark of Nyctanthus arbor- tristis 
Linn were investigated for their anthelmintic activity against pheretima posthuma. 
Three concentrations (20,40and 60 mg/ml) of each extracts were studied. It involves 
the determination of time of paralysis and time of death of the worm.   Albendazole in 
same concentration as that of extract was included as standard reference and 
distilled water as control. The anthelmintic activity of alcohol and aqueous extracts of 
Nyctanthes arbor-tristis Linn has therefore been compared and demonstrated for the 
first time 56. 
 2.3.7.4 Analgesic and Anti inflammatory activity  
                 The analgesic activity of aqueous and ethanolic leaves extract of 
Nyctanthes arbor-tristis, it was found from the percentage inhibition index that 
ethanolic extract shown better analgesic than aqueous extract when compared with 
standard drug aspirin. The methanolic extract of the stem bark of Nyctanthes arbor-
tristis shows statistically significant analgesic activity (by all four applied models) 
compared with control, standard. The result of treatment with the extracts of 
Nyctanthes arbor-tristis was similar with the standard and it showed significant 
analgesic activity57. Petroleum ether extract was found to be most active for 
analgesic activity and hence subjected to activity-guided fractionation. 
 The significant and dose-dependent activity showed by β-sitosterol (5, 10 and 20 
mg/kg, i.p.) comparable with the standard extract. β-Sitosterol from N. arbor-tristis 
leaves might be responsible for analgesic and anti-inflammatory activity58. The 
ethanolic extract obtained from the orange tubular of calyx of NAT and the isolated 
carotenoid (200 mg/kg, i.p.) possess significant inhibition of carangeenan-induced rat 
paw oedema using diclofenac sodium as a standard drug. The anti-inflammatory 
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activity against acute inflammatory oedema in rats using different phlogiston agents 
like carrageen in, formalin, histamine, 5-hyroxytrypatamine and hyluronidase 
significantly showed by aqueous soluble fractions of NAT ethanolic extract59. 
2.3.7.5. Hypoglycemic activity 
              Hypoglycemic activity of methanolic extracts of Nyctanthes arbor-tristis Linn. 
root in alloxan induced diabetic rats;  This research aims to investigate the 
hypoglycemic activity of methanolic extract of Nyctanthes arbor -tristis Linn. Root in 
alloxan induced diabetic albino rats. A comparison was made between the action of 
Nyctanthes arbor-tristis Linn. methanolic extract and a known anti diabetic drug 
glibenclamide (0.5mg/kg p.o).The methanolic extract of Nyctanthes arbor-tristis Linn. 
root was administered orally at different doses to normal rats. The methanol extract 
at 500 mg/kg dose level exhibited significant (p<0.05) hypoglycemic activity60. The 
ant diabetic activity of methanol extract of root of Nyctanthes arbor-tristis Linn is 
comparable to that of diabetic control animals. It is concluded that methanol extract 
of root of Nyctanthes arbor-tristis Linn possess safe and strong anti diabetic activity. 
2.3.7.6. Larvicidal activity 
                The larvicidal activity of saraca indica, Nyctanthes arbor-tritis, and clitoria 
ternatea extracts against three against three mosquito vector species, Screening of 
natural products for mosquito larvicidal activity against three major mosquito vectors 
Aedes aegypti, Culex quinquefasciatus, and Anopheles stephensi resulted in the 
identification of three potential plant extracts viz., Saraca indica/asoca, Nyctanthes 
arbor-tristis L., and clitoria ternate for mosquito larval control. In the case of S. 
indica/asoca, the petroleum ether extract of the leaves and the chloroform extract of 
the bark were effective against the larvae of C. quinquefasciatus with respective LC 
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(50) values 228.9 and 291.5 ppm. The LC (50) values of chloroform extract of N. 
arbor-tristis leaves were 303.2, 518.2, and 420.2 ppm against A. aegypti, A. 
stephensi, and C. quinquefasciatus, respectively. The methanol and chloroform 
extracts of flowers of N. arbor-tristis showed larvicidal activity against larvae of A. 
stephensi with the respective LC (50) values of 244.4 and 747.7 ppm. Among the 
methanol extracts of C. ternatea leaves, roots, flowers, and seeds, the seed extract 
was effective against the larvae of all the three species with LC(50) values 65.2, 
154.5, and 54.4 ppm, respectively, for A. stephensi, A. aegypti, and C. 
quinquefasciatus. Among the three plant species studied for mosquito larvicidal 
activity, C. ternatea produced the most promising mosquito larvicidal activity. The 
phytochemical analysis of the promising methanolic extract of the seed extract was 
positive for carbohydrates, saponins, terpenoids, tannins, and proteins. In 
conclusion, bioassay-guided fractionation of effective extracts may result in 
identification of a useful molecule for the control of mosquito vectors61. 
2.3.7.7. In vitro anti-oxidant activity 
                    Under most pathological conditions there is generation of reactive 
oxygen species and other free radicals. An increase in the antioxidant reserves of 
the organism can reduce oxidative stress and some of the plant-derived agents may 
help to reduce it. Nyctanthes arbor-tristis leaf extracts are extensively used in Indian 
traditional Medicine. In the present study we have examined the in vitro antioxidant 
activity of leaves and stem of the plant. The antioxidant activities of different 
concentrations of ethanol extracts of NAT-L and NAT-S were determined by DPPH 
radical scavenging assay, Reducing power ability, Hydrogen peroxide scavenging 
assay and Total antioxidant assay. The effective antioxidant activity of NAT-S and 
NAT-L has found increased with increasing concentration. Comparing NAT-S, there 
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was an increased activity found in NAT-L extract62. The results obtained in the 
present study indicate that the leaves and stems of Nyctanthes arbor-tristis are a 
potential source of natural antioxidants. 
 
 2.3.7.8. Immuno pharmacological activity 
                   The immuno-pharmacological properties of ethanolic extract of 
Nyctanthes arbor-tristis Linn. (NA) has been investigated. After administration of 
Nyctanthes arbor-tristis in doses of 0.25 and 0.5 g/kg body weight (BW) a significant 
increase in phagocytic index, leukocyte count and splenic antibody secreting cells 
were noticed. Stimulation of humoral immune response was further observed with 
heamagglutination antibody titre. This extract was further submitted to Thin Layer 
Chromatography (TLC) and High performance liquid chromatography (HPLC) and it 
confirmed the presence of methoxylated flavonoid quercetin-3, 3’-dimethoxy-7-
rhamnoglucopyranose. The results suggested that bio active compound flavonol 
glycoside of Nyctanthes arbor-tristis influences both humoral as well as cell mediated 
immune system63. 
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  CHAPTER - 3 
AIM AND OBJECTIVES 
Myocardial infarction (MI) is an irreversible necrosis of tissue of a region of 
myocardium caused by ischemia, which is a perfusion imbalance between demand 
and supply of blood to the heart via the coronary circulation. There is substantial 
evidence that ischemic tissue generates oxygen - derived free radical (oxygen 
radicals). Recently, attention has been focused on non- nutrient phytochemical and 
Triterpenoids and polyphenols such as the flavonoids, alkaloids, and xanthones 
derived from different plant species as potential therapeutic agents in the prevention 
and management of cardiovascular diseases due to their antioxidant nature.  
Medicinal plants are believed to be an important source of new chemical 
substances with potential therapeutic effects. Nyctanthes arbo-tristis plant contains 
potential antioxidant phytochemical such as Triterpenoids, polyphenols, flavonoids 
and related compounds have received increasing attention for their potential role in 
prevention of human diseases. Phytotherapeutics need a scientific approach to 
deliver the components in a sustained manner to increase patient compliance and 
avoid repeated administration. One such novel approach is nanotechnology. Nano-
sized drug delivery systems of herbal drugs have a potential future for enhancing the 
activity and overcoming problems associated with plant medicines.  
Hence, integration of the nanocarriers as a novel drug delivery system in the 
traditional medicine system is essential to conflict more chronic diseases like 
asthma, diabetes, cancer, CVS disorders and others. The present study is aim to 
synthesis ZnNPs of Nyctanthes arbo-tristis and evaluates the cardioprotective 
activity against ISO induced myocardial infarction in rats.  
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OBJECTIVES 
 Synthesis and characterization of ZnO-NAT using hydroalcoholic leaf extract 
of Nyctanthus arbor-tristis. 
 Evaluation of cardio protective potential of ZnNPs of Nyctanthes arbo-tristis by 
studying its effect on lipid peroxidation, myocyte injury marker (cardiac marker 
enzymes) and histopathological changes in model of isoproterenol induced 
myocardial necrosis in rats. 
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CHAPTER - 5 
PLAN OF STUDY 
 
         1. Collection and identification of plant material 
         2. Preparation of Plant extract 
         3. Synthesis of zinc oxide Nanoparticles. 
         4. Characterization of synthesized zinc oxide Nanoparticles. 
                    a) UV-Vis spectroscopy (UV-Vis), 
                    b) Fourier Transform Infrared Spectroscopy (FTIR), 
                    c) Transmission Electron Microscopy (TEM)  
                    d) Scanning Electron Microscopy (SEM) 
                    e) Power x ray Diffraction Analysis (XRD) 
         5. Pharmacological study design 
                    a)  Selection of animals 
                    b)  Animal grouping 
         6. Acute toxicity studies 
         7. Induction of myocardial infarction using ISO 
         8. Physical evaluation 
                   a)  Body weight 
                   b)  Feed intake 
         9. Biochemical estimation 
                   a) Total cholesterol (TC) 
                   b)  Triglycerides (TG) 
                   c)  High density lipoprotein (HDL) 
                   d)  Low density lipoprotein (LDL)    
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         10. Cardiac markers enzymes 
                    a)  Creatinine phosphokinase (CPK) 
                    b)  Aminotransferase (AST) 
                    c)  Alanine amino transferase (ACT) 
                    d)  Lactate dehydrogenase (LDH) 
                    e)  Alkaline phosphate (ALP) 
           11. Histopathalogical examination 
           12. Statistical analysis 
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CHAPTER-5 
MATERIALS AND METHODS 
5.1. Drugs and Chemicals 
Isoprenaline hydrochloride (isoproterenol) was purchased from Sigma 
Chemical Co. (St. Louis, MO, USA). All the chemicals and reagents used in this 
study were of analytical grade. Propranolol was purchased from the manufacturer 
Cipla Pharmaceuticals, Mumbai. 
5.2. Collection and authentication of plant material 
Leaves of Nyctanthes arbor-tristis were collected from in and around the 
region of Namakkal, Tamilnadu, in the month of November. The plant was 
authenticated by Dr. G.V.S. Murthy, Joint Director, Botanical Survey of India, 
Coimbatore, Tamilnadu, India. A voucher specimen is preserved in our laboratory for 
future reference.   
5.3. Preparation of plant extract  
The plants material was shade dried at room temperature. The dried plant 
materials were subjected to size reduction to a coarse powder by using dry grinder 
and passed through sieve no. 40 was used for extraction. Powdered plant material 
(500 gm) was extracted with 80% methanol at room temperature for 72 hrs. The 
extract was filtered and concentrated to dryness under reduced pressure and 
controlled temperature (400 C to 500 C) in a rotary evaporator until all solvent was 
removed to give a dark colored molten extract. The percentage yield of the 
methanolic leaf extract of Nyctanthes arbor-tristis was 72%. The extract was stored 
in airtight containers in refrigerator maintained below 100 C until further use.  
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5.4. Synthesis of ZnO NPs 64 
              1 mM Zinc acetate was dissolved in 50 ml Milli-Q water and                           
                                             Stirrer for 1 h respectively. 
 
           20 mL of NaOH solution was slowly added into the Zinc acetate solution 
  
                                      25 mL of plant extract was added 
              The colour of the reaction mixture was changed after 1 h of incubation time. 
 
     Solution was left in stirrer for 3 h Yellow colour appeared after the  incubation   
time                       confirmed the synthesis of ZnO NPs 
 
    Precipitate was separated and centrifugation at 8000 rpm at 60 °C for 15 min 
 
    pellet was collected and dried  hot air oven at 80 °C for 2 h and preserved. 
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                                         Fig.No:13 Synthesis of ZnO NPs 
5.5. CHARACTERIZATION OF ZnO NANOPARTICLES 
5.5.1. UV –Visible Spectroscopy 
           For UV- Visible spectra of synthesized ZnO nanoparticles were re-suspended 
in equal amount of sterilized de-ionised water and spectrum scans were performed 
using Shimadzu UV-1800 Spectrophotometer. 2 ml solution of the nanoparticles was 
taken in quartz cuvette. The scan range was set between 200-800nm and the 
background was minimised using de-ionised water.  
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5.5.2. Fourier Transform Infrared (FT-IR) Spectroscopy 
            The characterisation of phytoconstituents of Nyctanthes arbor-tristis hydro 
alcoholic extract involved in the reduction and stabilization of zinc nanoparticles was 
investigated by FT-IR analysis (Shimadzu- IR Affinity-1) and the spectra was 
scanned in the range of 4000-500 cmˉ1 range at a resolution of 4 cmˉ1.The sample 
was prepared by grounding the ZnO nanoparticles uniformly in a matrix of dry KBr, 
compressed to form an almost transparent disc. KBr was used as a standard to 
analyse the sample. 
5.5.3. Transmission Electron Microscopy (TEM)  
            TEM technique was used to visualize the morphology of the nanoparticles 
and determination of the size, shape and arrangement of particles. The ZnO 
nanoparticles was suspended in sterile deionised water, sonicated for 15 min and 
diluted to yield slightly turbid suspension. The suspension was then coated onto a 
copper grid and allowed to dry. TEM images were taken on the Philips CM200 7500 
model with resolution 2.4 A0 operating at voltage 20-200kv. 
5.5.4. Scanning Electron Microscopy (SEM)  
             The morphological features of synthesized ZnO nanoparticles from NAT 
plant extract were studied by Scanning Electron Microscope (JSM-6480 LV). After 
24Hrs. of the addition of ZnO the SEM slides were prepared by making a smear of 
the solutions on slides. A thin layer of platinum was coated to make the samples 
conductive. Then the samples were characterized in the SEM at an accelerating 
voltage of 20 KV. 
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 5.5.5. X Ray Diffraction Analysis (XRD) 
               The XRD pattern of the synthesized nanoparticles was then recorded using 
Analytical PW3040/60 XpertPRO model X-ray diffractometer. A thin flim of the 
sample was made by dipping a glass plate for XRD studies. The instrument was 
operated at a current of 30mA and voltage of 40KV.The size was calculated using 
Scherer formula.  
                                              =   0.94 𝝀 
                                                   β cosθ 
                                  Where, 
                                          D = crystal size, 
                                         λ = wavelength of X-ray, 
                                         Ѳ = Bragg’s angle 
                          β= Full width at half maxima (FWHM) of spectral peak (in radians) 
5.6. Evaluation of cardio protective effect 
5.6.1. Experimental Animals 
            The colony inbred female albino wistar Rats , Weighing 150-300gm were 
obtained from Central Animal house of Swamy Vivekananda college of pharmacy, 
Elayampalayam,  Namakkal  -637 205. The animals were kept under standard 
environmental conditions of 12/12light/dark rhythm, maintained under controlled 
room temperature (23±2ºC) and a relative humidity of 60%± 10%, in polypropylene 
cages. They were fed with standard pellet diet and water ad libitum. The immature 
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animals were acclimatized under laboratory conditions three days prior to initiation of 
the experiment. The cages were cleaned daily by changing the husk bedding. 
            The experimental protocol was approved by the institutional Animal Ethical 
Committee (IAEC) of Swamy Vivekananda college of pharmacy, Elayampalayam, 
Namakkal -637 205.Care and use of laboratory animals were confirmed to CPCSEA 
guidelines. 
IAEC Approval No.: SVCP/IAEC/PG/2/04/2018 
5.6.2. Induction of Myocardial Infarction Using Isoproterenol 65 
              Myocardial Infarction was induced by dissolving Isoproterenol hydrochloride 
in normal saline and was injected subcutaneously (s.c.) 85mg/kg body weight for two 
consecuetive days into rats at an interval of 24 hr to induce experimental MI (14 th  & 
15th day).  
5.6.3. Animal grouping 
            The experimental rats were divided into four groups of six animals each and 
treated as follows:  
Group 1: Normal control animals receiving normal saline (2ml/kg/day) once daily for 
15 days. 
Group 2:  Negative-control animals receiving normal saline (2ml/kg/day) once daily 
for 15 days and treated with isoproterenol (ISO) (85mg/kg, s.c.) on 14th&15th day. 
Group 3:  Animals receiving standard drug propranolol (10mg/kg/day) orally 15 days 
and challenged with isoproterenol (ISO) (85mg/kg, s.c.) on 14th&15th day. 
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Group 4: Animals receiving hydroalcholic extract NAT–ZnO NP (500mg/kg/day) 
orally for 15 days and challenged with isoproterenol (ISO) (85mg/kg, s.c.) on 
14th&15th day. 
Group 5:  Animals receiving higher dose NAT –ZnO NP (30 mg/kg/day) orally for 15 
days and challenged with isoproterenol (ISO) (85mg/kg, s.c.) on 14th&15th day. 
5.7. Acute toxicity studies  
             Acute toxicity study was conducted in accordance with Organisation for 
Economic Cooperation and Development (OECD) guidelines for testing of acute oral 
toxicity (AOT) by up and down procedure (UDP) OECD- No: 425 
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                                                  Figure.no:14: OECD Guidelines 425 
 
 
5.8. Physical evaluation 
5.8.1 Measurement of body weight 
          Body weight of each rats in all groups were measured weekly till end of the 
treatment using a weighing balance and the changes were recorded. 
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5.8.2 Measurement of Feed intake 
          Daily feed consumption was measured in individual treatment groups by using 
standard weighing balance. 
5.9. Biochemical estimation 
      At the end of experimental period on 14th  day rats were fasted overnight (12 h) 
and blood samples were collected via retro-orbital sinus puncture under mild 
anaesthesia. Serum was obtained by centrifugation of samples at 3000 rpm for 10 
min and used for further plasma lipid profile and cardiac specific injury markers 
estimations.  
5.9.1. Serum lipid profile  
Serum total cholesterol (TC), triglycerides (TG), high density lipoprotein (HDL) 
and Low density lipoproteins (LDL) were analysed by using commercially available 
laboratory kits (ARKRAY Healthcare Pvt. Ltd., surat, India).  
 
5.9.2. Serum cardiac specific injury markers  
Activity levels of creatine phospokinase-MB (CK-MB), lactate dehydrogenase 
(LDH), Alanine transaminase (ALT), aspartate transaminase (AST) and alkaline 
phosphatase (ALP) in serum were estimated using commercially available kits 
(AGAPPE Diagnostics LTD,  Kerala, India). 
 
5.10. Histopathological Evaluation 
              Histological evaluation was performed on lower portion of the heart tissue. 
Fresh heart tissues were excised and then fixed in 10% formalin for 24 hr. The 
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fixative was removed by washing through running tap water for overnight. After 
dehydration through a graded serious of alcohols, the tissues were cleaned in methyl 
benzoate, embedded in paraffin wax. Section were cut into 5 μm thickness and 
stained with hematoxylin and eosin. After repeated dehydration and cleaning, the 
sections were mounted and observed under light microscope with 100x 
magnification for histological changes.   
  5.11. Statistical analysis 
 The results of cardio protective activities are expressed as mean ± SEM from four 
animals from each group. Results were analysed statistically by one way ANOVA 
followed by post hoc Dunnet’s test by using  SPSS  V.17(student trail version).The 
difference was considered significant when p<0.05. 
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CHAPTER-6 
RESULTS 
6.1. CHARACTERIZATION OF ZnO NANOPARTICLES 
6.1.1. UV –Visible Spectroscopy 
             The zinc oxide nanoparticles were efficiently synthesized from Nyctanthus 
arbor-tristis leaf extract with zinc acetate at the ratio of 1:10.With in 30 mins of 
incubation the dark brown colour changes, an indicator of zinc oxide nanoparticles 
formation. The green synthesized zinc oxide nanoparticles showed absorbance from 
250 to 265 nm and the absorbance centred at 260nm in UV-visible spectroscopy. 
The UV-visible absorbance spectra result enlightens that the nanoparticles were 
found to be symmetrical with spherical polydispersed in nature.  
 
 
 
 
 
 
 
                                      
Fig. No.: 15 UV –Visible spectroscopy 
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6.1.2 Transmission Electron Microscopy (TEM)  
            TEM analysis was performed in order to investigate the morphological and 
distribution of our green synthesized zinc oxide nanoparticles.TEM analysis revealed 
that all the nanoparticles were found in general as spherical shape. The average 
particle size measured from the TEM images is found to be 50nm        
       
                      
                                 
 
 
 
 
 
 
 
 
 
 
                             Fig.No: 16.Transmission Electron Microscopy                                                                             
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6.1.3 Scanning Electron Microscopy (SEM)  
                   The analysis of the scanning electron microscopy (SEM) images predicts 
the formation and the morphology of stable zinc oxide nanoparticles obtained from 
the current green approach. The images showed the presence of both individual as 
well as the aggregated ZnONPs. The ZnONPs are mainly uniform spherical shaped 
with the average range of particle size distribution from 40 nm to 80 nm. 
                   
       
Fig.No:17.Scanning Electron Microscopy (SEM) 
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6.1.4 Fourier Transform Infrared Spectroscopy 
               Fourier transform infrared (FT-IR) spectroscopy helps establish the identity 
of various phyto-chemical constituents involved in the reduction and stabilization of 
the nanoparticles. FT-IR spectrum for dried and powdered ZnO NPs was obtained 
using Perkin Elmer FT-IR Spectrophotometer Frontier using the technique of 
Attenuated Total Reflectance (ATR) in the range of 4000–400 cm. The sample for 
the infrared analysis was carefully prepared to exclude any possibility of the 
presence of any unbound plant extract residue. The similarities between the spectra 
with some marginal shifts in peak position, clearly indicate the presence of the 
residual plant extract in the sample as a capping agent to the ZnO NPs. FT-IR 
spectroscopy was performed. The FTIR spectra resulted in various peaks at 3262, 
2923.56, 1567.84, 1406.82 and 1035.59 cm-1. The peaks at 3262 correspond to H 
bonded OH stretch and NAH stretch. Peak at 2923.56 corresponds to stretching 
vibrations of C triple bond C stretch of alkynes. The 1567.84 peak results from the 
stretching bands of C=O functional groups. The peak at 1406.82 refers to the amine 
-NH vibration stretch in protein amide linkages The 1035.59 peak results from 
aromatic amines. 
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        Fig No.: 18. FT-IR Pattern of the ZnONP of Nyctanthes arbor-tristis leaf 
extract 
 
6.1.5 .X ray Diffraction Analysis 
                 Washed and dried sample of ZnO NPs was used for XRD analysis using 
Ultima IV at the wavelength of 1.5406 A °. XRD was performed in the 2h range of 
20–80 degrees at 40 kV and 40 mA with a divergence slit of 10 mm in 2h/h 
continuous scanning mode. Crystal lattice indices and particle size calculations were 
performed using the X-ray diffraction pattern of ZnO NPs Diffraction peaks were 
observed at 2h values of 31.80o, 34.44o, 36.24 o, 47.48 o, 56.62 o, 62.88 o, 66.42 o, 
68.0 o and 69.14 o corresponding to lattice planes (100), (002), (101), (102), (110), 
(103), (200), (112) and (201) respectively. The peaks have been attributed to 
hexagonal phase of ZnO  
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  Interplanar d-spacing was calculated using Bragg’s Law equation  
                           2d sinθ=nλ 
                           where,  
                                  θ is Bragg’s angle of diffraction,  
                                λ is X-ray wavelength, i.e. 1.5406 A ° and n= 1. 
Further, particle size was calculated from the intense peak corresponding to (101) 
plane using Debye–Scherrer formula 
                         D ¼ 0:89k=b cosθ 
                            where  
                               0.89= Scherrer’s constant, 
                                    k= X-ray wavelength 
The value of particle siz was found to be 18.34nm which falls within the size 
range of 15-48 nm reported by TEM and XRD.    
 
                           Figure.:19. Power X-Ray Diffraction Analysis 
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6.2 Changes in body weight 
               Body weight of the animals of all groups was measured at trial period, initial 
and a final body weight change in treatment group was compared with control group. 
Initially there were no significant changes in body weight between treatment groups 
when compared to the control group. On 15th day weight of ZnO NAT treated group 
showed significantly increase in body weight compared to other groups. 
 
Treatment Initial body 
weight(g) 
Final body weight(g) 
Normal control 164.5± 10.03 225.3±16.26 
Diseases control 173.3±12.07 232.4±14.73a * * * 
Standard 
(Propronolol) 
163.6±11.16 215.0±10.57 b * * * 
HE of 
NAT(500mg/kg) 
167.3±8.73 235.21±6.54 b * * * 
ZnO NAT (30mg/kg) 176.7±10.23 298.3±15.79 b* * * 
 
                       Table. No:1 Changes in body weight 
 
Values are expressed as mean ± SEM, n=6. Comparisons were made between: 
a- Group I vs II, III ,IV and V b- Group II vs I,III ,IV and V 
Symbols represent statistical significance: #=P<0.001, $=P<0.01,* = P<0.05  
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                  Graph.No:1 Changes in body weight 
     
 6.3 Effect of NAT ZnO-NPs on isoproterenol-induced changes in Serum 
cardiac specific injury markers 
The activities of cardiac functional marker enzymes (CPK, LDH, AST, ALT 
and ALP) in the serum of isoproterenol alone treated group shown significant 
increases as compare to the normal control group rats. Though the pre treatment of 
ZnO NPs NAT (50mg/kg) related groups significantly prevented the depletion of 
myocardial enzymes as compared to the negative control. ZnO NPs NAT (50mg/kg) 
treatment, however, did not show any significant effect on the activity of ALP 
enzyme.  
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Table.No :2  Effect of HENA on Marker enzymes of Rats Myocardial serum 
Group AST  ALT ALP LDH CK-MB 
Normal control 17.01±1.48*** 15.56±2.25*** 95.20±3.14** 213.2±12.59*** 65.95±15.04 
Diseases 
control 
50.02±4.25*** 52.07±3.17*** 228.7±9.05*** 328.9±16.63*** 140.6±4.45 
Standard 50.80±1.05 
a 
33.01±1.05 a# 130.9±7.09 a# 
a# 
269.46±11.09 
a# 
76.08±1.02  
HE of 
NAT(500mg/kg) 
39.06±2.34*** 49.42±3.15b*** 
 
145.04±3.15a** 
 
298.09±1.64 
*** 
123.35±9.08  
 ZnO NAT                                        
(30mg/kg) 
16.9±1.08 
b*** 
22.36±1.36 
b*** 
 
118.78±2,08 
b* 
 
210.8±2.08 
b*** 
 
112.06±1.67  
 
 
Values are expressed as mean ± SEM, n=6. Comparisons were made between: 
a- Group I vs II, III ,IV and V b- Group II vs I,III ,IV and V 
Symbols represent statistical significance: #=P<0.001, $=P<0.01,* = P<0.05  
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Graph.No :2  Effect of HENA on Marker enzymes of Rats Myocardial serum 
6.4 Effect of ZnO NP-NAT on isoproterenol- induced changes in serum Lipid 
profile 
         The results of ZnO NPs NAT on isoproterenol induced changes in serum lipid 
profile are cited in Table 2. The level of serum total cholesterol, triglycerides, LDL 
significantly increases and decrease in the levels of HDL in isoproterenol treatment 
as compartment to control group. The treatment ZnO NPs NAT of for 15 days 
however, significantly restored the lipid profile to near normalcy as compared to the 
negative control. 
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Table.No :3 Effect of ZnO NP-NAT on isoproterenol- induced changes in serum 
Lipid profile 
Treatments TC (mg/dl) TG(mg/dl) HDL(mg/dl) LDL(mg/dl) 
Normal control 108.17 ± 
4.98 
95.67 ± 4.09  49.33 ± 5.38  99.83 ± 4.71  
Diseases 
control 
177.67 ± 
8.11a# 
144.50 ± 5.46 
a# 
33.17 ± 3.99 
a* 
128.83 ± 7.85 
a* 
Standard 169.5 ±5.32 134.42 ±7.01 33.17 ±5.87 119.6 ±4.23 
HE of 
NAT(500mg/kg) 
127.31 ± 
7.18a* b# 
115.83 ± 6.98 
a* b$ 
38.00 ± 4.03 112.66 ± 7.01 
ZnO NAT                                        
(30mg/kg) 
108.24 ± 
6.18 b# 
96.00 ± 6.92 
b# 
48.67 ± 5.00 
b* 
97.17 ± 5.71 
b* 
 
Values are expressed as mean ± SEM, n=6. Comparisons were made between: 
a- Group I vs II, III and IV. And V b- Group II vs III and IV,V 
Symbols represent statistical significance: #=P<0.001, $=P<0.01,* = P<0.05  
 
Results 
 
M.Pharm Project Page 67 
 
 
 Graph.No:3 Effect of ZnO NP-NAT on isoproterenol- induced changes in         
serum Lipid profile 
6.5  Histopathological observations 
        Histopathological examination of myocardial tissue from normal control animals 
exhibited clear integrity of myocardial membrane. Histopathological findings 
confirmed the induction of myocardial infarction by isoproterenol. Heart tissues from 
isoproterenol treated rats showed widespread myocardial structure disorder and sub 
endocardial necrosis with capillary dilatation and leukocyte infiltration as compared 
to normal control rats. Treatment of hydroalcoholic extract of NAT 500mg/kg showed 
mild muscle separation and few inflammatory cells, lower dose of 50mg/kg treatment 
showed no change in histo-architecture of heart tissue as compared to normal 
control rats. 
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A) Control                                              B) Diseases control 
                               
                    C) Standard                                          D) HE-NAT 
                                 
                                                     E) ZnO NAT 
                                           
                                    Fig.,20. Histopathological Examination 
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CHAPTER-7 
DISCUSSION 
            zinc oxide nanoparticles (ZnO- NP) as a material of low toxicity, because zinc 
is an essential trace element in the human body and is commonly present in foods or 
added as a nutritional supplement, so zinc attracts little attention towards  
assessment of toxicity using nanoparticles. The fact that zinc appears to have 
protective effects in coronary artery diseases and cardiomyopathy is attributed to its 
critical role in redox signalling pathway, whereby certain triggers such as ischemia 
and infarction leads to release of zinc from proteins and cause myocardial damage2 
In that the plant extract  of nyctanthus arbor-tristis is synthesised in the form of 
nanoparticles. 
             IN UV-Visible ,the zinc oxide nanoparticles were efficiently synthesized from 
Nyctanthus arbor-tristis leaf extract with zinc acetate at the ratio of 1:10.With in 30 
mins of incubation the dark brown colour changes, an indicator of zinc oxide 
nanoparticles formation. The green synthesized zinc oxide nanoparticles showed 
absorbance spectra at 260nm in UV-visible spectroscopy. The UV-visible 
absorbance spectra result enlightens that the nanoparticles were found to be 
symmetrical with spherical polydispersed in nature. 
TEM analysis was performed in order to investigate the morphological and 
distribution of our green synthesized zinc oxide nanoparticles.TEM analysis revealed 
that all the nanoparticles were found in general as spherical shape. The average 
particle size measured from the TEM images is found to be 50nm.  The analysis of 
the scanning electron microscopy (SEM) images predicts the formation and the 
morphology of stable zinc oxide nanoparticles obtained from the current green 
approach. The images showed the presence of both individual as well as the 
aggregated ZnONPs. The ZnONPs are mainly uniform spherical shaped with the 
average range of particle size distribution from ...nm. 
 
Fourier transform infrared (FT-IR) spectroscopy helps establish the identity of 
various phyto-chemical constituents involved in the reduction and stabilization of the 
nanoparticles.FT-IR spectrum for dried and powdered ZnO NPs was obtained using 
Perkin Elmer FT-IR Spectrophotometer Frontier using the technique of Attenuated 
                                                                                              Discussion 
 
M.Pharm Project Page 70 
 
Total Reflectance (ATR) in the range of 4000–400 cm. The sample for the infrared 
analysis was carefully prepared to exclude any possibility of the presence of any 
unbound plant extract residue. The similarities between the spectra with some 
marginal shifts in peak position, clearly indicate the presence of the residual plant 
extract in the sample as a capping agent to the ZnO NPs. FT-IR spectroscopy was 
performed. The FTIR spectra resulted in various peaks at 3340.6, 3258.2, 2127.8, 
1641.1, 1456.7, 1362.5, 1040, 1026.8, 746.25, 620.65 cm-1 The peaks at 3340.6 and 
3258.2 correspond to H bonded OH stretch and NAH stretch. Peak at 2127.8 
corresponds to stretching vibrations of C „ C stretch of alkynes. The 1641.1 peak 
results from the stretching bands of C‚O functional groups . The peak at 1456.7 
refers to the amine -NH vibration stretch in protein amide linkages The 1362.5 peak 
results from aromatic amines and the two peaks at 1040 and 1026.8 from C-N 
stretch of aliphatic amines. The 746.25 and 620.65 peaks correspond to alkanes and 
supposedly, C-H bend in alkynes. 
 
                  In Xray diffraction, ZnO NPs was used for XRD analysis using Ultima IV 
at the wavelength of 1.5406 A °. XRD was performed in the 2h range of 20–80 
degrees at 40 kV and 40 mA with a divergence slit of 10 mm in 2h/h continuous 
scanning mode. Crystal lattice indices and particle size calculations were performed 
using the X-ray diffraction pattern of ZnO NPs Diffraction peaks were observed at 2h 
values of 31.80, 34.44, 36.24, 47.48, 56.62, 62.88, 66.42, 68.0and 69.14 
corresponding to lattice planes (100), (002),(101), (102), (110), (103), (200), (112) 
and (201) respectively. The peaks have been attributed to hexagonal phase of ZnO. 
                    Many of today’s diseases including cardiac diseases have been linked 
to oxidative stress which is initiated by the reaction of free radicals with biological 
macromolecules such as proteins, lipids and DNA. Generally antioxidants, preferably 
from natural sources, have been considered as effective treatments.   
                 Isoproterenol produces relative ischemia or hypoxia due to myocardial 
hyperactivity and coronary hypotension and induce myocardial ischemia due to 
cytosolic Ca2+ overload The oxidative stress may be exerted through quinone 
metabolites of isoproterenol, which reacts with oxygen to produce ROS and interfere 
with glutathione reductase), superoxide dismutase and ATP pumps . 
                   Oleanolic acid is a lipophilic β-blocker in nature. β-Adrenergic blockers 
have long been useful adjuvants in the management of myocardial ischemic 
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syndromes. The myocardial necrosis observed in the animals receivingisoproterenol 
can also be attributed to peroxidative damageas it has been previously reported that 
isoproterenol generateslipid peroxides. 
              ISO induced myocardial necrosis has been reported to alter 
membrane permeability and to cause leakage of marker enzymes of cardiac damage 
(LDH, CK-MB, AST, ALT and ALP) into the blood stream.81 Significantly elevated 
levels of these marker enzymes have been recorded in IP induced myocardial 
damage.82 Result of this study assures that significant elevated level of marker 
enzymes LDH, CK-MB, AST, ALT and ALP in IP alone treated group as compared to 
the normal control. On the contrary, ZnO NP NAT treatment protected the structure 
and functional integrity of myocardial membrane as evident from the significant 
reduction in the elevated levels of these serum marker enzymes in the rats when 
compared to the isoproterenol treated rats. Increase in the activity of these enzymes 
is diagnostic indicators of myocardial infarction83 and are indicative of cellular 
damage and loss of functional integrity of cell membrane.84 The reversal of these 
enzyme activities by pretreatment with ZnO NP NAT indicates its therapeutic 
potential against myocardial infarction in a dose dependent manner by preventing 
the ISO induced leakage of marker enzymes.  
Histopathological examination of myocardial tissue in control illustrated clear 
integrity of the myocardial cell membrane and no inflammatory cell infiltration was 
observed. Isoproterenol injected rats showed coagulative necrosis, separation of 
cardiac muscle fibres and infiltration of inflammatory cells. The reduced inflammatory 
cell infiltration and normal cardiac muscle fibre architecture further confirmed the 
cardioprotective effect of ZnO NP NAT in a dose dependent manner. 
From the present study it is clear that the ZnO nanoparticles in Nyctanthus 
arbor tristis shows the significant cardioprotective activity at both doses against ISO 
induced myocardial infarction it is difficult to establish the mechanism of action for 
cardioprotection against induced myocardial infarction but the presence of 
Phytochemicals such as oleanoic acid,alkaloids,Flavanoids, Saponin, Amino acid 
may plays a vital role against ISO induced myocardial damage by its cardioprotective 
activity. 
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CHAPTER - 8 
SUMMARY AND CONCLUSIONS 
Myocardial infarction occurs when there is imbalance between coronary 
blood supply and myocardial demands which results in the acute condition of 
necrosis of myocardium. MI is the common presentation of the ischemic heart 
disease. Even though clinical care is improved, public awareness is raised and 
health innovations are widely used, myocardial infarction still remains the leading 
cause of death worldwide. In our study isoproterenol was used to induce MI in 
rats, because of this pathological changes mimics the human MI.. Hence in our 
study methanolic leaf extract of ZnO NAT  was used for evaluating the in vivo 
cardioprotective activity against isoproterenol induced MI. 
The treatment with ZnO NAT successfully restored serum lipid profile i.e. 
the elevated triglycerides, LDL-cholesterol, total cholesterol levels and also 
increases the HDL cholesterol levels at a dose dependent manner against the 
isoproterenol induced MI.  
And also result of this study indicate that the pretreatment of ZnO NAT 
prevent the elevation of cardiac activity marker enzymes LDH, CK-MB, AST, ALT 
and ALP against IP induced MI. It might be indicates the cardioprotective effect of 
Nyctanthus arbor tristis. Further histopathological analysis result conform the 
significant cardioprotective effect of hydro alcoholic leaf extract of Nyctanthus 
arbor tristis against IP induced MI. 
Nyctanthes arbo-tristis plant contains potential antioxidant phytochemical 
such as Triterpenoids, polyphenols, flavonoids and related compounds have 
received increasing attention for their potential role in prevention of human 
diseases. Phytotherapeutics need a scientific approach to deliver the components 
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in a sustained manner to increase patient compliance and avoid repeated 
administration. One such novel approach is nanotechnology. Nano-sized drug 
delivery systems of herbal drugs have a potential future for enhancing the activity 
and overcoming problems associated with plant medicines. ZnO NAT   is a more 
potent compared to Hydroalcoholic extract. 
Based on the present study it could be concluded that subcutaneous 
injections of isoproterenol induced myocardial infarction in rats as identified by the 
release of myocyte injury markers and altered lipid profile in serum. 
Cardioprotective effect of ZnO NAT was proved by reduction in cardiac marker 
enzymes, altered lipid profile and histopathological studies. In comparison to the 
hydro alcoholic extract ZnO nano particle of NAT treatment poses more potent 
cardioprotective effect. Further investigation is needed to explore the active 
principles and exact mechanism of action of Nyctanthus arbor tristis plant in 
prevention and treatment of cardio vascular disorders. 
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